2016-10-18,Cynapsus Therapeutics Obtains Final Court Order And HSR Waiting Period Expires For Plan Of Arrangement With Sunovion Pharmaceuticals
2016-10-13,Cynapsus Therapeutics Securityholders Approve The Plan Of Arrangement With Sunovion Pharmaceuticals
2016-09-28,ISS Recommends Cynapsus Therapeutics Securityholders Vote For The Plan Of Arrangement
2016-09-08,Cynapsus Therapeutics Inc. Acquisition May Not Be In The Best Interests Of CYNA Shareholders
2016-09-06,CYNAPSUS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Cynapsus Therapeutics Inc. (CYNA) Over The Proposed Sale Of The Company To Sunovion Pharmaceuticals Inc.
2016-09-01,Stocks Get Off to Shaky September Start in Wait for Jobs Report
2016-09-01,Why Cynapsus Therapeutics (CYNA) Stock Is Soaring Today
2016-08-29,Cynapsus Receives FDA Fast Track Designation For APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease
2016-08-15,Cynapsus Announces Positive Opinion From Data And Safety Monitoring Board On Phase 3 Parkinson's Disease Clinical Study Allowing For At-Home Titration
2016-08-12,Cynapsus Announces Publication In The Journal Movement Disorders Of Data For The Treatment Of OFF Episodes In Patients With Parkinson's Disease
2016-08-10,Cynapsus Therapeutics Reports Second Quarter 2016 Financial Results And Recent Developments
2016-07-18,Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results With APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease
2016-07-18,Cynapsus Therapeutics Provides European Clinical Update For APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease
2016-07-06,Cynapsus Therapeutics Announces 2016 Analyst And Investor Day
2016-06-30,Cynapsus Therapeutics Enrolls Last Patient In Pivotal Phase 3 Efficacy Trial Of APL-130277 To Treat OFF Episodes In Patients With Parkinson's Disease
2016-06-21,Cynapsus Therapeutics Announces Data Presentations At The International Congress Of Parkinson's Disease And Movement Disorders
2016-05-30,Cynapsus Therapeutics Announces Data Presentations At The European Academy Of Neurology Annual Meeting
2016-05-20,Cynapsus Therapeutics Appoints Frederick Driscoll To Its Board Of Directors
2016-05-11,Cynapsus Therapeutics Reports First Quarter 2016 Financial Results And Recent Developments
2016-05-11,Cynapsus Therapeutics Announces Results Of AGM
2016-04-28,Cynapsus Therapeutics To Present At Several Upcoming Investor Conferences
2016-04-15,Cynapsus Therapeutics Announces Data Presentations At The American Academy Of Neurology Annual Meeting
2016-04-04,Cynapsus Therapeutics And MonoSol Rx Announce Global IP Licensing Agreement
2016-03-17,Cynapsus Therapeutics is Now Oversold (CYNA)
2016-03-09,Cynapsus Therapeutics Reports Financial Results For The Fourth Quarter And Year Ended 2015
2016-03-07,Cynapsus Therapeutics Provides Company Update At Cowen & Co. 36th Annual Health Care Conference
2016-03-01,Cynapsus Therapeutics To Present At Cowen & Co. 36th Annual Health Care Conference
2016-02-09,Relative Strength Alert For Cynapsus Therapeutics
2016-01-13,Cynapsus Therapeutics To Present At Noble Financial Capital Markets Twelfth Annual Investor Conference
2016-01-07,Cynapsus And Michael J. Fox Foundation Collaborate On Pilot Use Of Wearable Device And Data Science Approaches In Phase 3 Parkinson's Clinical Study
2016-01-07,Cynapsus And Michael J. Fox Foundation Collaborate On Pilot Use Of Wearable Device And Data Science Approaches In Phase 3 Parkinson's Clinical Study
2016-01-04,Cynapsus Therapeutics Completes Short-Form Amalgamation With Wholly-Owned Subsidiary
2015-12-14,Relative Strength Alert For Cynapsus Therapeutics
2015-12-10,Cynapsus Therapeutics Announces Successful Completion Of Bioavailability And Pharmacokinetic Study And Provides Update On European Clinical Plans
2015-12-08,Cynapsus Therapeutics Announces Positive Data Presentations At World Congress On Parkinson's Disease And Related Disorders Meeting
2015-11-19,Cynapsus Therapeutics Expands Senior Leadership Team
2015-11-13,Cynapsus Therapeutics To Present At Stifel 2015 Healthcare Conference
2015-11-12,Cynapsus Therapeutics Reports Third Quarter 2015 Financial Results And Recent Developments
2015-09-03,Cynapsus Therapeutics To Present At Two Upcoming Healthcare Conferences
2015-09-02,Cynapsus Therapeutics Enrolls First Patient In Pivotal Phase 3 Safety Study Of APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease
2015-08-11,Cynapsus Therapeutics Enters Oversold Territory (CYNA)
2015-07-30,Cynapsus CEO Says IPO Funds Will Help Parkinson’s Patients Get Unstuck
2015-07-30,Parkinson’s Drug Delivery System on Track Says Cynapsus CEO
2015-07-16,OTC Markets Group Announces Second Quarter 2015 Index Performance And Rebalancing
,
,
,
,
